TLR4 mediates inflammation and hepatic fibrosis induced by chronic intermittent hypoxia in rats Corrigendum in /10.3892/mmr.2021.12144

Lin,Zhi‑Peng; Lin,Hui‑Li; Yu,Xue‑Ping; Zheng,Yi‑Juan; Cheng,Si‑Yu

doi:10.3892/mmr.2020.11134

TLR4 mediates inflammation and hepatic fibrosis induced by chronic intermittent hypoxia in rats

Corrigendum in: /10.3892/mmr.2021.12144

Authors:
- Zhi‑Peng Lin
- Hui‑Li Lin
- Xue‑Ping Yu
- Yi‑Juan Zheng
- Si‑Yu Cheng
View Affiliations

Affiliations: Department of Infectious Diseases, The First Quanzhou Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, P.R. China, Department of Cardiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, P.R. China
Published online on: May 7, 2020 https://doi.org/10.3892/mmr.2020.11134
Pages: 651-660
Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Obstructive sleep apnea syndrome (OSAS) is a common and complex disorder that is associated with liver injury. Moreover, previous studies have revealed that chronic intermittent hypoxia (CIH) is associated with the development of non‑alcoholic fatty liver disease and hepatic fibrosis. However, the underlying molecular mechanisms remain largely unknown. The present study aimed to investigate whether chronic intermittent hypoxia induced hepatic fibrosis, in addition to determining its underlying mechanisms, in CIH model rats using immunohistochemistry, western blotting and reverse transcription‑quantitative PCR. The present results suggested that CIH caused hepatic fibrosis and increased the expression levels of interleukin (IL)‑1β, IL‑8, monocyte chemotactic‑1, tumor necrosis factor‑α, intercellular adhesion molecule‑1 and vascular cell adhesion molecule‑1 in the liver; these conditions could be reversed by Toll‑like receptor 4 (TLR4) short hairpin RNA lentivirus treatment. Moreover, immunohistochemistry and western blotting results indicated that TLR4 and NF‑κB expression levels were significantly increased in the CIH and CIH‑TLR4 empty vector lentivirus group. However, protein expression levels of TLR4, NF‑κB, inhibitor of NF‑κB and phosphorylated‑mitogen‑activated protein kinase (MAPK)‑1 in the hypoxia/reoxygenation group were significantly higher compared with the control group (P<0.05), and these results were reversed by the MAPK inhibitor U0126 in vitro. Collectively, the present preliminary results suggested that inflammation and the TLR4/NF‑κB/MAPK signaling pathway may be involved in CIH‑induced liver fibrosis.

View Figures

View References

1	Philip P, Bioulac S, Altena E, Morin CM, Ghorayeb I, Coste O, Monteyrol PJ and Micoulaud-Franchi JA: Specific insomnia symptoms and self-efficacy explain CPAP compliance in a sample of OSAS patients. PLoS One. 13:e01953432018. View Article : Google Scholar : PubMed/NCBI
2	Paschetta E, Belci P, Alisi A, Liccardo D, Cutrera R, Musso G and Nobili V: OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease. Mediators Inflamm. 2015:8157212015. View Article : Google Scholar : PubMed/NCBI
3	Arnold J, Sunilkumar M, Krishna V, Yoganand SP, Kumar MS and Shanmugapriyan D: Obstructive sleep apnea. J Pharm Bioallied Sci. 9 (Suppl 1):S26–S28. 2017. View Article : Google Scholar : PubMed/NCBI
4	O'Halloran KD, Lewis P and McDonald F: Sex, stress and sleep apnoea: Decreased susceptibility to upper airway muscle dysfunction following intermittent hypoxia in females. Respir Physiol Neurobiol. 245:76–82. 2017. View Article : Google Scholar : PubMed/NCBI
5	Kang NY, Ivanovska J, Tamir-Hostovsky L, Belik J and Gauda EB: Chronic intermittent hypoxia in premature infants: The link between low fat stores, adiponectin receptor signaling and lung injury. Adv Exp Med Biol. 1071:151–157. 2018. View Article : Google Scholar : PubMed/NCBI
6	Chen Q, Lin G, Huang J, Chen G, Huang X and Lin Q: Expression profile of long non-coding RNAs in rat models of OSA-induced cardiovascular disease: New insight into pathogenesis. Sleep Breath. 23:795–804. 2019. View Article : Google Scholar : PubMed/NCBI
7	Coelho NR, Dias CG, João Correia M, Grácio P, Serpa J, Monteiro EC, Diogo LN and Pereira SA: Cysteine oxidative dynamics underlies hypertension and kidney dysfunction induced by chronic intermittent hypoxia. Adv Exp Med Biol. 1071:83–88. 2018. View Article : Google Scholar : PubMed/NCBI
8	Aron-Wisnewsky J, Clement K and Pépin JL: Nonalcoholic fatty liver disease and obstructive sleep apnea. Metabolism. 65:1124–1135. 2016. View Article : Google Scholar : PubMed/NCBI
9	Sozer V, Kutnu M, Atahan E, Caliskaner Ozturk B, Hysi E, Cabuk C, Musellim B, Simsek G and Uzun H: Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome. Clin Respir J. 12:1615–1622. 2018. View Article : Google Scholar : PubMed/NCBI
10	Wu CX, Liu Y and Zhang JC: Chronic intermittent hypoxia and hypertension: A review of systemic inflammation and Chinese medicine. Chin J Integr Med. 19:394–400. 2013. View Article : Google Scholar : PubMed/NCBI
11	Ryan S and McNicholas WT: Inflammatory cardiovascular risk markers in obstructive sleep apnoea syndrome. Cardiovasc Hematol Agents Med Chem. 7:76–81. 2009. View Article : Google Scholar : PubMed/NCBI
12	Drager LF, Tavoni TM, Silva VM, Santos RD, Pedrosa RP, Bortolotto LA, Vinagre CG, Polotsky VY, Lorenzi-Filho G and Maranhao RC: Obstructive sleep apnea and effects of continuous positive airway pressure on triglyceride-rich lipoprotein metabolism. J Lipid Res. 59:1027–1033. 2018. View Article : Google Scholar : PubMed/NCBI
13	Ropert C: How toll-like receptors reveal monocyte plasticity: The cutting edge of antiinflammatory therapy. Cell Mol Life Sci. 76:745–755. 2019. View Article : Google Scholar : PubMed/NCBI
14	Mohan S and Gupta D: Crosstalk of toll-like receptors signaling and Nrf2 pathway for regulation of inflammation. Biomed Pharmacother. 108:1866–1878. 2018. View Article : Google Scholar : PubMed/NCBI
15	Chowdhury P, Sacks SH and Sheerin NS: Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products. Clin Exp Immunol. 145:346–356. 2006. View Article : Google Scholar : PubMed/NCBI
16	González-Guerrero C, Cannata-Ortiz P, Guerri C, Egido J, Ortiz A and Ramos AM: TLR4-mediated inflammation is a key pathogenic event leading to kidney damage and fibrosis in cyclosporine nephrotoxicity. Arch Toxicol. 91:1925–1939. 2017. View Article : Google Scholar : PubMed/NCBI
17	Mukherjee S, Karmakar S and Babu SP: TLR2 and TLR4 mediated host immune responses in major infectious diseases: A review. Braz J Infect Dis. 20:193–204. 2016. View Article : Google Scholar : PubMed/NCBI
18	Zhou M, Xu W, Wang J, Yan J, Shi Y, Zhang C, Ge W, Wu J, Du P and Chen Y: Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-κB pathway quenches intestinal inflammation and oxidative stress injury. EBioMedicine. 35:345–360. 2018. View Article : Google Scholar : PubMed/NCBI
19	Hu H and Li H: Prunetin inhibits lipopolysaccharide-induced inflammatory cytokine production and MUC5AC expression by inactivating the TLR4/MyD88 pathway in human nasal epithelial cells. Biomed Pharmacother. 106:1469–1477. 2018. View Article : Google Scholar : PubMed/NCBI
20	Yuan X, Deng Y, Guo X, Shang J, Zhu D and Liu H: Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway. Biochem Biophys Res Commun. 446:292–297. 2014. View Article : Google Scholar : PubMed/NCBI
21	Deng Y, Yuan X, Guo XL, Zhu D, Pan YY and Liu HG: Efficacy of atorvastatin on hippocampal neuronal damage caused by chronic intermittent hypoxia: Involving TLR4 and its downstream signaling pathway. Respir Physiol Neurobiol. 218:57–63. 2015. View Article : Google Scholar : PubMed/NCBI
22	Viciani E, Montagnani F, Tavarini S, Tordini G, Maccari S, Morandi M, Faenzi E, Biagini C, Romano A, Salerni L, et al: Paediatric obstructive sleep apnoea syndrome (OSAS) is associated with tonsil colonisation by Streptococcus pyogenes. Sci Rep. 6:206092016. View Article : Google Scholar : PubMed/NCBI
23	Dong Z, Shang H, Chen YQ, Pan LL, Bhatia M and Sun J: Sulforaphane protects pancreatic acinar cell injury by modulating Nrf2-Mediated oxidative stress and NLRP3 inflammatory pathway. Oxid Med Cell Longev. 2016:78641502016. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
25	Zeng X, Guo R, Dong M, Zheng J, Lin H and Lu H: Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression. J Transl Med. 16:1062018. View Article : Google Scholar : PubMed/NCBI
26	Ryan S, Taylor CT and McNicholas WT: Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 112:2660–2667. 2005. View Article : Google Scholar : PubMed/NCBI
27	Ye J, Liu H, Li Y, Liu X and Zhu JM: Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Chin Med J (Engl). 120:1482–1486. 2007. View Article : Google Scholar : PubMed/NCBI
28	Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Torbenson MS and Polotsky VY: Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol. 293:G871–G877. 2007. View Article : Google Scholar : PubMed/NCBI
29	de Lima FF, Mazzotti DR, Tufik S and Bittencourt L: The role inflammatory response genes in obstructive sleep apnea syndrome: A review. Sleep Breath. 20:331–338. 2016. View Article : Google Scholar : PubMed/NCBI
30	Tamaki S, Yamauchi M, Fukuoka A, Makinodan K, Koyama N, Tomoda K, Yoshikawa M and Kimura H: Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. Intern Med. 48:1255–1262. 2009. View Article : Google Scholar : PubMed/NCBI
31	Wang H, Wang Y, Xia T, Liu Y, Liu T, Shi X and Li Y: Pathogenesis of abnormal hepatic lipid metabolism induced by chronic intermittent hypoxia in rats and the therapeutic effect of N-acetylcysteine. Med Sci Monit. 24:4583–4591. 2018. View Article : Google Scholar : PubMed/NCBI
32	Song D, Fang G, Mao SZ, Ye X, Liu G, Gong Y and Liu SF: Chronic intermittent hypoxia induces atherosclerosis by NF-κB-dependent mechanisms. Biochim Biophys Acta. 1822:1650–1659. 2012. View Article : Google Scholar : PubMed/NCBI
33	Morgan BJ, Bates ML, Rio RD, Wang Z and Dopp JM: Oxidative stress augments chemoreflex sensitivity in rats exposed to chronic intermittent hypoxia. Respir Physiol Neurobiol. 234:47–59. 2016. View Article : Google Scholar : PubMed/NCBI
34	Lüneburg N, Siques P, Brito J, Arriaza K, Pena E, Klose H, Leon-Velarde F and Böger RH: Long-Term chronic intermittent hypobaric hypoxia in rats causes an imbalance in the asymmetric dimethylarginine/nitric oxide pathway and ROS activity: A possible synergistic mechanism for altitude pulmonary hypertension? Pulm Med. 2016:65785782016. View Article : Google Scholar : PubMed/NCBI
35	Al-Anazi A, Parhar R, Saleh S, Al-Hijailan R, Inglis A, Al-Jufan M, Bazzi M, Hashmi S, Conca W, Collison K and Al-Mohanna F: Intracellular calcium and NF-κB regulate hypoxia-induced leptin, VEGF, IL-6 and adiponectin secretion in human adipocytes. Life Sci. 212:275–284. 2018. View Article : Google Scholar : PubMed/NCBI
36	Yang X, Chen GT, Wang YQ, Xian S, Zhang L, Zhu SM, Pan F and Cheng YX: TLR4 promotes the expression of HIF-1α by triggering reactive oxygen species in cervical cancer cells in vitro-implications for therapeutic intervention. Mol Med Rep. 17:2229–2238. 2018.PubMed/NCBI
37	Masoud GN and Li W: HIF-1α pathway: Role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
38	Ullah K, Rosendahl AH, Izzi V, Bergmann U, Pihlajaniemi T, Mäki JM and Myllyharju J: Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways. Sci Rep. 7:172202017. View Article : Google Scholar : PubMed/NCBI
39	Fu D, He C, Wei J, Zhang Z, Luo Y, Tan H and Ren C: PGK1 is a potential survival biomarker and invasion promoter by regulating the HIF-1α-mediated epithelial-mesenchymal transition process in breast cancer. Cell Physiol Biochem. 51:2434–2444. 2018. View Article : Google Scholar : PubMed/NCBI
40	Shirasuna K, Shimamura N, Seno K, Ohtsu A, Shiratsuki S, Ohkuchi A, Suzuki H, Matsubara S, Nagayama S, Iwata H and Kuwayama T: Moderate hypoxia down-regulates interleukin-6 secretion and TLR4 expression in human Sw.71 placental cells. Cell Physiol Biochem. 36:2149–2160. 2015. View Article : Google Scholar : PubMed/NCBI
41	Menon D, Coll R, O'Neill LA and Board PG: GSTO1-1 modulates metabolism in macrophages activated through the LPS and TLR4 pathway. J Cell Sci. 128:1982–1990. 2015. View Article : Google Scholar : PubMed/NCBI
42	Siegert I, Schodel J, Nairz M, Schatz V, Dettmer K, Dick C, Kalucka J, Franke K, Ehrenschwender M, Schley G, et al: Ferritin-mediated iron sequestration stabilizes hypoxia-inducible factor-1α upon LPS activation in the presence of ample oxygen. Cell Rep. 13:2048–2055. 2015. View Article : Google Scholar : PubMed/NCBI
43	Funami K, Matsumoto M, Oshiumi H, Inagaki F and Seya T: Functional interfaces between TICAM-2/TRAM and TICAM-1/TRIF in TLR4 signaling. Biochem Soc Trans. 45:929–935. 2017. View Article : Google Scholar : PubMed/NCBI
44	Zhang X, Du Q, Yang Y, Wang J, Dou S, Liu C and Duan J: The protective effect of luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway. Biomed Pharmacother. 91:1042–1052. 2017. View Article : Google Scholar : PubMed/NCBI
45	Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ, Agnew ML, Hampton CR, Rothnie CL, Spring DJ, et al: Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation. 114 (1 Suppl):I270–I274. 2006. View Article : Google Scholar : PubMed/NCBI
46	Takahashi T, Asano Y, Ichimura Y, Toyama T, Taniguchi T, Noda S, Akamata K, Tada Y, Sugaya M, Kadono T and Sato S: Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis. Arthritis Rheumatol. 67:254–265. 2015. View Article : Google Scholar : PubMed/NCBI